{"issuance_frequency":"","notes_translated":{"fr":"Compte tenu de l'éclosion de la COVID-19, Santé Canada clarifie ses attentes concernant l'exigence de déclarer les effets indésirables (EI) et incidents liés aux matériels médicaux (IMM) pendant une pandémie pour les fabricants, importateurs et détenteurs d'une autorisation de mise sur le marché (DAMM).\r\n","en":"In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"10bcc3d5-bc58-47a5-accc-900cefed0582","metadata_created":"2020-04-03T17:00:47.178534","subject":["government_and_politics","health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-04-07T16:40:42.807897","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-04-03","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Avis à l'intention de l’industrie","éclosion de la COVID-19","pandémie"],"en":["Notice for Industry","COVID-19 outbreak","pandemic"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Avis à l'intention de l’industrie: exigence de déclaration obligatoire pendant la pandémie de la COVID-19","en":"Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"10bcc3d5-bc58-47a5-accc-900cefed0582","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c6c4fc88-feb3-4255-89b4-eb5c704bf4da","related_relationship":"","name_translated":{"fr":"Avis à l'intention de l’industrie: exigence de déclaration obligatoire pendant la pandémie de la COVID-19","en":"Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic","language":["en"],"created":"2020-04-03T17:00:47.353053","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-industry-mandatory-reporting-requirement-covid-19-pandemic.html","last_modified":null,"position":0,"revision_id":"2781821b-b92e-4d5b-ac0e-fff4a1505ab4","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"10bcc3d5-bc58-47a5-accc-900cefed0582","datastore_active":false,"id":"a849a9f1-cefa-4ed9-a1a1-8aeb5f470bff","character_set":"","state":"active","name_translated":{"fr":"Avis à l'intention de l’industrie: exigence de déclaration obligatoire pendant la pandémie de la COVID-19","en":"Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic","language":["fr"],"created":"2020-04-03T17:00:47.353060","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-industrie-exigence-declaration-obligatoire-pandemie-covid-19.html","last_modified":null,"position":1,"revision_id":"2781821b-b92e-4d5b-ac0e-fff4a1505ab4","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-04-03 00:00:00","date_created":"2020-03-23","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"10bcc3d5-bc58-47a5-accc-900cefed0582","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.\r\n","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic","revision_id":"2781821b-b92e-4d5b-ac0e-fff4a1505ab4"}